Peer Review History
| Original SubmissionFebruary 19, 2021 |
|---|
|
PONE-D-21-05595 In-silico identification, expressional profile and regulatory network analysis of Mitogen Activated Protein Kinase Kinase Kinase gene family in C. sinensis PLOS ONE Dear Dr. Mishra, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 29 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Tapan Kumar Mondal, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information. Additional Editor Comments (if provided): The work is good but needs improvement. I am agree with the reviewers about the issues raised by them. In addition I suggest to add the classical and related paper on tea biotechnology which are missing:- 1. Mukhopadhyay et al (2016) Plant Cell Rep 35(2):255-87. 2. Bordoloi et al (2021). Physiol Mol Biol Plants 27, 369–385 [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Comments to the Authors Please find the attachments (pdf version of manuscript & supplementary files) for details. In this work, authors have carried out genome-wide In-silico identification, expressional profile and regulatory network analysis of Mitogen Activated Protein Kinase Kinase Kinase gene family in C. sinensis by retrieval of genome, proteome & gene expression data from TPIA database. There is no error in terms of the technical aspects of the work done through bioinformatics approach and the information generated is presented in an appropriate way. Though, the manuscript is well written, there are some minor corrections and clarifications needs to be made before it is accepted for publication that will help to improve the readability & presentation of the work. Further, authors need to do an additional work which is very common part of genome wide In-silico mining of gene families. The authors need to retrieve the genomic DNA sequences upstream of the transcriptional start site for each tea MAPKKK gene from TPIA database for identifying putative promoter cis-acting elements. For identifying cis elements, the authors may use PlantCARE database (http://bioinformatics.psb.ugent.be/webtools/plantcare/html/). All the corrections needed to be done are highlighted and commented in the pdf version of the manuscript & supplementary files provided. The questions pertaining to the text in the manuscript which needs to be answered are also provided as comments in the manuscript pdf version. Please find the attached pdf version of manuscript & supplementary files for comments. Few points where correction & revision (Minor revision) is required are given below & commented in details in the pdf version of the manuscript and supplementary files. 1. Few grammatical and typographical errors needs to be corrected. 2. All the abbreviated forms are required to be written in their full form at the first instance of their occurrence. 3. Reframing of few sentences is required. 4. Few questions related to homologous/orthologous gene pairs and few others questions needed to be answered. 5. For some statements references need to be cited. 6. Some typographical error regarding the total number of plant tissue samples whose expression have been analysed need to be corrected. 7. Some figures caption/legend description needs to be corrected. 8. Specific tissue names whose expression was analysed under different abiotic stress treatment & MeJA treatment needs to be mentioned. 9. Throughout the discussion in many instances some sentences almost seemed to be repetitive or similar to what was already mentioned in introduction and result section. Authors are advised to cross check this and modify or reframe the sentences wherever needed. 10. Scientific names need to be italicized in the Supplementary Tables captions. For Example- C.sinensis. 11. In the supplementary figures: the heatmap labels, the numbers at the bottom and alphabets on the right side, each needs to be described specifically what they correspond to. Major Revision Additional Work: The authors need to retrieve the genomic DNA sequences upstream of the transcriptional start site for each tea MAPKKK gene from TPIA database for identifying putative promoter cis-acting elements. For identifying cis elements, the authors may use PlantCARE database (http://bioinformatics.psb.ugent.be/webtools/plantcare/html/). Reviewer #2: 1) Few MAPKKK genes identified In-silico genome wide analysis from C. sinensis genome in this study should be validated by wet lab. 2) The identified MAPKKK genes in different subfamilies should not just be based on their phylogenetic relationships. 3) The network of functionally interacting genes should also include the genes that have experimentally validated support. 4) Expression profile analysis by qRT-PCR is required to reveal the involvement of the tea MAPKKK genes in various tissues during development and under various abiotic stress stimuli and plant hormonal treatment. 5) The study should decipher a model of signalling mechanism mediated by MAPKKK genes cascade in tea. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Madhurjya Gogoi Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-21-05595R1 In-silico identification, expressional profile and regulatory network analysis of Mitogen Activated Protein Kinase Kinase Kinase gene family in C. sinensis PLOS ONE Dear Dr. Mishra, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Especially, queries raised by the Reviewer#3 on the title and statistics need to be addressed. Please submit your revised manuscript by Sep 25 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ramegowda Venkategowda, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #3: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have substantially improved the revised manuscript and incorporated all the necessary changes required. I am satisfied with the authors response on the queries asked. However, before it is accepted for publication, I would like to know a bit about the process of orthologous gene identification authors have employed for my clarification. • Did the authors use all the Arabidopsis MEKK, Raf and ZIK genes accession one by one and looked for the orthologs in C.sinenis TPIA database Orthologous Groups search option? • Does TPIA database Orthologous Groups search option includes all the C.sinensis gene accessions that are orthologous to other species? For future similar kind of work, I would advise authors to incorporate synteny analysis between the organism of interest and a model or reference organism. It is not required for this paper now. Authors just needs to address the concern I have raised above regarding orthologous gene identification. Further, authors need to make few minor changes in the manuscript before acceptance. (1) I have strikeout and underlined few words in some sentences and also provided comments on those within the revised manuscript pdf file (revised manuscript with track changes part of the pdf file). Please find the attached file. Authors are advised to incorporate the required changes. (2) The authors need to correct the legends of Fig 9, Fig 10, Fig 11, Fig 12. The relative expression of the genes were analysed in the leaves of C.sinensis in different stages and not in different tissues for the Fig 9, Fig 10, Fig 11, Fig 12. Authors wrote “The relative expression of these genes were analysed in different tissues by using GraphPad Prism 8 software”. Authors need to incorporated the corrected legend for Fig 9, Fig 10, Fig 11, Fig 12. The corrected legend for Fig 9, Fig 10, Fig 11, Fig 12 are given below: Fig 9. Gene expression patterns of (A) MEKK (B) Raf and (C) ZIK genes, under cold stress conditions in C. sinensis. The relative expression of these genes were analysed in different stages by using GraphPad Prism 8 software. The level of expression was in transcript per million (TPM). Fig 10. Gene expression patterns of (A) MEKK (B) Raf and (C) ZIK genes, under drought stress conditions in C. sinensis. The relative expression of these genes were analysed in different stages by using GraphPad Prism 8 software. The level of expression was in transcript per million (TPM). Fig 11. Gene expression patterns of (A) MEKK (B) Raf and (C) ZIK genes, under salt stress conditions in C. sinensis. The relative expression of these genes were analysed in different stages by using GraphPad Prism 8 software. The level of expression was in transcript per million (TPM). Fig 12. Gene expression patterns of (A) MEKK (B) Raf and (C) ZIK genes, under Methyl jasmonate (MeJA) treatment in C. sinensis. The relative expression of these genes were analysed in different stages by using GraphPad Prism 8 software. The level of expression was in transcript per million (TPM) Reviewer #3: The authors of this study used an insilico approach for phylogenetic, structural and functional characterization of the MAPKKK gene family in tea. The authors use standard bioinformatics methods for the analysis and the results seem to match expectations. While most of these methods are well-described in the revised version, I have a few additional concerns that must be addressed before publication. Major: -The title is suggestive of a rigorous regulatory network analysis of MAPKKK in tea. However, this does not seem to be the case here. In its current form, this network analysis pipeline makes no sense because no biological knowledge about tea kinases is extracted and highlighted anywhere in the MS. Furthermore, apart from the title, several other parts of the MS are misleading. In methods, the network analysis section suggests that a network of all orthologs between tea and arabidopsis was built, but in results it seems only one gene was used as a guide. 1) Explain why only one gene and why that one? 2) I am curious to know how many of the original 59 genes (also mentioned in the abstract) are part of the network shown?. The authors can also show the overlaps, if any, between the interacting partners of all tea kinases that match Arabidopsis kinases. 3) How does the network shown tell us about the predicted kinases? In my opinion, a better network analysis strategy could be employed, or the title should be modified to reflect other important analysis performed (e.g. phylogenetic analysis). -The authors mention that they used GO analysis for predicting gene function. However, the authors did not perform any statistical tests to support the results. GO analysis is not really a prediction method, but in this case, it can be used to validate one’s expectation from the nature of the study (e.g. terms like ‘protein phosphorylation’). Please describe the following points in greater detail: 1) Exactly how was the GO analysis performed? The link provided does not work. Did you use sequences (Blast2GO?), gene IDs, or ortholog gene IDs as input to topGO? 2) Is the overlap between tea genes with GO terms shown in Fig. S8 statistically significant? Same goes for CC and MF analysis. Minor: 1) Figure legends should not be repetitions of the methods. Please clearly explain in the legend what is shown in the plot, specially in the supplemental figures Fig. S1-3. You should not expect a general reader to already know the outputs of TMHMM Server. What do probabilities above 1 mean? What are the red peaks? 2) The tradition set by the original creators of GO is to refer to them as ‘ontologies’ and ‘terms’, rather than ‘groups’ and ‘subgroups’, respectively. Please rephrase to stick with the convention. 3) In the abstract, the sentence “..on the basis of orthologous genes in Arabidopsis, functional interaction was carried out in C. sinensis.” is suggestive of wet-lab experiments. Please rephrase to clearly reflect network analysis of one of the 59 genes the story revolves around. 4) Page 19: I believe that the lines between “Similarity search programs like BLAST…...tend to possess similar functions” are to provide a logical reasoning for your approach of using Arabidopsis network in STRING. If this is the case, please rephrase these lines to reflect the exact logic. It’s somewhat confusing in its current form. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Madhurjya Gogoi Reviewer #3: Yes: Chirag Gupta [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
In-silico genome wide analysis of Mitogen Activated Protein Kinase Kinase Kinase gene family in C. sinensis PONE-D-21-05595R2 Dear Dr. Mishra, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ramegowda Venkategowda, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: No |
| Formally Accepted |
|
PONE-D-21-05595R2 In-silico genome wide analysis of Mitogen Activated Protein Kinase Kinase Kinase gene family in C. sinensis Dear Dr. Mishra: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ramegowda Venkategowda Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .